Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN), ISIN INE448G01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NATHBIOGEN last traded at ₹161.15 (-1.47%), with a 52-week range of ₹126.75 to ₹207.00 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 45.60%, FIIs 0.23%, DIIs 0.01%, mutual funds 0.01%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.